Deepak Nitrite Ltd (DNL)

Executive Summary Deepak Nitrite Ltd, through its wholly-owned subsidiary Deepak Chem Tech Ltd, has successfully commenced manufacturing operations at its new Nitric Acid plant today, December 4, 2025. This development represents a critical step in the company’s capital expenditure cycle and strategic integration roadmap. Key Highlights Capex Deployment: The facility was commissioned with a total capital expenditure of approximately ₹515 crore. Strategic Integration: The plant significantly strengthens DNL’s backward and forward integration capabilities. It advances the group’s evolution into a fully integrated chemical platform spanning from Ammonia to Amines—a specialized capability held by a limited number of global players. Operational Benefits: Supply Security: Reinforces internal supply security for critical intermediates. Value Chain Resilience: Enhances the company's ability to withstand market volatility by controlling key inputs. High-Value Entry: Enables deeper penetration into high-value downstream applications. Financial Context & Market Reaction Stock Performance: Following the announcement, shares of Deepak Nitrite ended the session at ₹1,536.40, up by 0.96% on the BSE. Recent Performance: This commissioning is a positive structural development following a challenging Q2 FY26 (Quarter ended Sept 30, 2025), where consolidated net profit corrected by ~39% YoY to ₹118.7 crore due to higher input costs and softer demand. The new facility is expected to aid in margin stabilization and long-term volume growth. Investor Takeaway The operationalisation of the Nitric Acid plant marks the transition from capex to operations, potentially unlocking operating leverage in coming quarters. It addresses key raw material dependencies, positioning Deepak Nitrite for better margin control despite current industry headwinds.